Filter
1191
Text search:
human
pharmaceutical
products
Featured
116
322
Language
Document type
554
260
191
72
70
15
14
8
4
2
1
Countries / Regions
59
51
38
36
28
27
26
26
24
22
20
18
18
17
16
15
15
14
13
12
12
12
12
11
11
9
9
8
7
6
6
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
488
84
62
57
32
23
9
1
Toolboxes
159
129
72
56
46
38
36
35
26
22
22
20
19
19
17
14
13
8
7
6
5
5
3
Prices people pay for medicines.
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in
...
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...
Health Systems in Transition. Vol. 5 No.3 2015
Towards a Healthier Botswana
